Cellect Biotechnology Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Cellect Biotechnology Ltd. (a foreign private issuer) covers the month of May 2020. The report addresses a corporate governance event regarding a special general meeting of shareholders convened on May 27, 2020.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
The primary material event reported is the adjournment of the special general meeting of shareholders originally scheduled for May 27, 2020. The meeting was adjourned due to a lack of quorum. No changes were made to the proposals to be voted on by shareholders.
Outlook and Management Commentary
- Rescheduled Meeting: The special general meeting has been rescheduled to Wednesday, June 3, 2020, at 11:00 a.m. (Israel Time).
- Location: The meeting will be held at the offices of the Company's legal counsel, Doron, Tikotzky, Kantor, Gutman, Nass & Amit Gross, located at B.S.R 4 Tower, 33rd Floor, 7 Metsada Street, Bnei Brak.
- Documentation: The Company's proxy statement and other materials filed with the SEC remain unchanged.
Key Facts for Investor Verification
- Verify the attendance and quorum status at the rescheduled meeting on June 3, 2020.
- Confirm the final voting results on the proposals once the meeting concludes.
- Review the unchanged proxy statement for details on the specific proposals being voted upon.